Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Total Liabilities (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Total Liabilities readings, the most recent being $69.1 million for Q4 2021.

  • On a quarterly basis, Total Liabilities rose 1293.06% to $69.1 million in Q4 2021 year-over-year; TTM through Dec 2021 was $69.1 million, a 1293.06% increase, with the full-year FY2021 number at $69.1 million, up 1293.06% from a year prior.
  • Total Liabilities hit $69.1 million in Q4 2021 for Minerva Neurosciences, roughly flat from $69.5 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $69.5 million in Q3 2021 to a low of $5.0 million in Q4 2020.
  • Median Total Liabilities over the past 3 years was $50.2 million (2020), compared with a mean of $43.9 million.
  • Biggest five-year swings in Total Liabilities: crashed 90.02% in 2020 and later skyrocketed 1293.06% in 2021.
  • Minerva Neurosciences' Total Liabilities stood at $49.7 million in 2019, then crashed by 90.02% to $5.0 million in 2020, then skyrocketed by 1293.06% to $69.1 million in 2021.
  • The last three reported values for Total Liabilities were $69.1 million (Q4 2021), $69.5 million (Q3 2021), and $69.2 million (Q2 2021) per Business Quant data.